Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Saved in:
Bibliographic Details
Title: Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Authors: Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK. katie.ewer@ndm.ox.ac.uk., Barrett JR; The Jenner Institute, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK., Sharpe H; The Jenner Institute, University of Oxford, Oxford, UK., Makinson R; The Jenner Institute, University of Oxford, Oxford, UK., Morter R; The Jenner Institute, University of Oxford, Oxford, UK., Flaxman A; The Jenner Institute, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, University of Oxford, Oxford, UK., Bellamy D; The Jenner Institute, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Provine NM; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aboagye J; The Jenner Institute, University of Oxford, Oxford, UK., Fowler J; The Jenner Institute, University of Oxford, Oxford, UK., Silk SE; The Jenner Institute, University of Oxford, Oxford, UK., Alderson J; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Berrie E; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Cicconi P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK., Green CM; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK., Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK., Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Tarrant R; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK., Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lambe T; The Jenner Institute, University of Oxford, Oxford, UK. Teresa.lambe@ndm.ox.ac.uk.
Corporate Authors: Oxford COVID Vaccine Trial Group
Source: Nature medicine [Nat Med] 2021 Jun; Vol. 27 (6), pp. 1116.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-021-01363-0